At the Neurowoche 2014 together with the 87th Congress of the German Society of Neurology (DGN) on September 16, 2014 in Munich, the results of three years of Internet-based care management of assistive devices in amyotrophic lateral sclerosis (ALS) with AmbulanzPartner will be presented in the scientific program.
Background: ALS is a prototypical disease for the complex provision of assistive devices including orthotics, electromobility and assisted communication. Despite high demand and widespread use, there are no systematic studies on the provision of assistive devices for ALS.
Since April 2011, the provision of medical aids for people with ALS has been realized via AmbulanzPartner. Case management and the digitalization of care processes allow real data on the provision of assistive devices to be recorded. The frequency distribution of ALS-typical aids and the rejection rates by payers were analyzed.
The predominant aids for ALS are orthoses, communication aids and power wheelchairs. The data analysis shows a high rejection rate by payers in individual groups of assistive devices as well as regional differences in care. At Neurowoche 2014, the discussion will focus on the relevance for health policy and the need for research into the high rejection rates by payers.
On December 4, 2025, the ALS app will be presented at the"ALS App Europe Initiative…
Following our last newsletter on the introduction of the OPM classification in the ALS app,…
You can now submit your e-prescription with your health card via the ALS app at…
We are pleased to introduce an important new feature in the ALS app today: The…
The THC:CBD patient survey is a systematic survey of 130 patients with amyotrophic lateral sclerosis…
We are pleased to inform you that we have completely revised our medication module. With…